Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now official registry

Pharmacokinetics clinical trials

Every US clinical trial registered for Pharmacokinetics — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

38 US clinical trials · 6 currently recruiting

The research picture

Pharmacokinetics has 38 registered US clinical trials, 6 of them open to new participants right now — about 16% of the total.

6
recruiting participants now
16%
of trials open to enrollment
5
in Phase 3–4 (later-stage)
2
top sponsor: Mutual Pharmaceutical Company

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING Phase 1 400 participants

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Amgen

NCT07422285

RECRUITING Phase 1 196 participants

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Nanjing Immunophage Biotech Co.

NCT05142592

RECRUITING Phase 1 46 participants

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Basilea Pharmaceutica

NCT06733675

RECRUITING Phase 4 40 participants

Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy

Milton S. Hershey Medical Center

NCT03737292

RECRUITING Phase 1 30 participants

High Potency Cannabis: Acute and Protracted Effects

University of California, Los Angeles

NCT06859723

RECRUITING Phase 1 30 participants

Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

Ensysce Biosciences

NCT06500793

ACTIVE NOT RECRUITING Phase 1 6 participants

A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects

Alzamend Neuro

NCT06921590

COMPLETED Phase 1 600 participants

Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration

Eagle Pharmaceuticals

NCT03324061

COMPLETED Phase 1 159 participants

Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects

Actelion

NCT02206204

COMPLETED Phase 4 102 participants

Pharmacokinetics of Aqueous Dexamethasone

Frank A. Bucci, Jr., M.D.

NCT04667507

COMPLETED Phase 1 55 participants

Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants

Janssen Scientific Affairs

NCT01464450

COMPLETED 45 participants

Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents

Children's Hospital Los Angeles

NCT01976078

COMPLETED Phase 1 40 participants

Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience

Altasciences Company

NCT06072170

COMPLETED Phase 4 40 participants

Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)

Takeda

NCT01084278

COMPLETED Phase 1 40 participants

PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

International Partnership for Microbicides

NCT05041699

COMPLETED Phase 4 38 participants

Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects

Pfizer

NCT01188668

COMPLETED Early Phase 1 36 participants

Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants

Daiichi Sankyo

NCT03614455

COMPLETED Phase 1 30 participants

Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients

Genfit

NCT03765671

COMPLETED Phase 4 28 participants

Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals

Amphastar Pharmaceuticals

NCT04207840

COMPLETED Phase 2 26 participants

A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents

Pfizer

NCT00556998

COMPLETED NA 26 participants

Interaction Between Cannabidiol, Meal Ingestion, and Liver Function

Colorado State University

NCT04971837

COMPLETED Phase 1 26 participants

A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy Subjects

Daiichi Sankyo

NCT02790671

COMPLETED Phase 1 25 participants

Effect of Delivery Route on PK of Sufentanil NanoTab

Talphera

NCT01639729

COMPLETED Phase 1 24 participants

Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics

Bayer

NCT01318265

COMPLETED Phase 1 24 participants

Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants

Basilea Pharmaceutica

NCT05527834

COMPLETED Phase 1 24 participants

A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice

Mutual Pharmaceutical Company

NCT00984009

COMPLETED Phase 1 24 participants

Drug-Drug Interaction Study Between Colchicine and Ketoconazole

Mutual Pharmaceutical Company

NCT00983216

COMPLETED Phase 1 18 participants

Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States

PepsiCo Global R&D

NCT05266248

COMPLETED 18 participants

Pharmacokinetics of Antiepileptics in Patients on CRRT

University of Maryland, Baltimore

NCT03632915

COMPLETED Phase 1 18 participants

Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration

Food and Drug Administration (FDA)

NCT04397445

COMPLETED Phase 1 14 participants

Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants

Alumis

NCT05330858

COMPLETED 14 participants

PET Imaging of Nicotinic Acetylcholine Receptors

National Institute on Drug Abuse (NIDA)

NCT01046513

COMPLETED Phase 1 12 participants

A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects

NeuroSense Therapeutics

NCT05232461

COMPLETED NA 12 participants

Pharmacokinetics of Two Fatty Acid Ketone Esters

BHB Therapeutics, Ireland

NCT05686083

COMPLETED Phase 1 10 participants

A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics

University of Florida

NCT03843502

COMPLETED NA 8 participants

Pharmacokinetic Profile of N-Acetyl Cysteine

University of Memphis

NCT06252519

COMPLETED Phase 1 7 participants

Pharmacokinetic Study of Raltegravir in Healthy Premenopausal Women.

University of North Carolina, Chapel Hill

NCT00746499

COMPLETED Phase 1 6 participants

RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE

Sumitomo Pharma America

NCT01082146

Phase Distribution

PhaseTrial count
Phase 1 26
Phase 2 1
Phase 4 5

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Pharmacokinetics Trial Landscape

ClinicalTrials.gov lists 38 US studies indexed under Pharmacokinetics, and 6 of those are currently open to recruitment — roughly 16% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Pharmacokinetics shows 5 late-stage studies (Phase 3 and Phase 4 combined) alongside 27 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Pharmacokinetics is led by Mutual Pharmaceutical Company with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 38 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Pharmacokinetics?

PlainTrial tracks 38 US clinical trials for Pharmacokinetics, of which 6 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Pharmacokinetics?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →